SMAD5 and diffuse large B-cell lymphoma: On the other hand, SMAD5-AS1 was reported to be downregulated in DLBCL since it inhibits DLBCL proliferation by sponging miR-135b-5p to ultimately upregulate APC expression and inhibit the Wnt/β-catenin pathway [100].